UXIN LTD - ADR (UXIN)

US91818X3061 - ADR

3.93  -0.03 (-0.76%)

After market: 3.96 +0.03 (+0.76%)

Fundamental Rating

1

Taking everything into account, UXIN scores 1 out of 10 in our fundamental rating. UXIN was compared to 123 industry peers in the Specialty Retail industry. Both the profitability and financial health of UXIN have multiple concerns. UXIN is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

UXIN had negative earnings in the past year.
In the past 5 years UXIN always reported negative net income.
In the past 5 years UXIN always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -58.75%, UXIN is doing worse than 95.04% of the companies in the same industry.
Industry RankSector Rank
ROA -58.75%
ROE N/A
ROIC N/A
ROA(3y)-56.61%
ROA(5y)-47.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UXIN has a Gross Margin of 3.45%. This is amonst the worse of the industry: UXIN underperforms 95.87% of its industry peers.
UXIN's Gross Margin has declined in the last couple of years.
UXIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-72.05%
GM growth 5Y-54.25%

0

2. Health

2.1 Basic Checks

UXIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UXIN has been increased compared to 1 year ago.
The number of shares outstanding for UXIN has been increased compared to 5 years ago.
UXIN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -9.22, we must say that UXIN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -9.22, UXIN is not doing good in the industry: 96.69% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.22
ROIC/WACCN/A
WACC7.57%

2.3 Liquidity

UXIN has a Current Ratio of 0.39. This is a bad value and indicates that UXIN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.39, UXIN is doing worse than 95.87% of the companies in the same industry.
UXIN has a Quick Ratio of 0.39. This is a bad value and indicates that UXIN is not financially healthy enough and could expect problems in meeting its short term obligations.
UXIN has a Quick ratio of 0.14. This is amonst the worse of the industry: UXIN underperforms 91.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.14

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 67.96% over the past year.
UXIN shows a strong growth in Revenue. In the last year, the Revenue has grown by 148.87%.
UXIN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.69% yearly.
EPS 1Y (TTM)67.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6060.2%
Revenue 1Y (TTM)148.87%
Revenue growth 3Y35.4%
Revenue growth 5Y14.69%
Sales Q2Q%-10.94%

3.2 Future

Based on estimates for the next years, UXIN will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.81% on average per year.
Based on estimates for the next years, UXIN will show a very strong growth in Revenue. The Revenue will grow by 87.81% on average per year.
EPS Next Y-4475.5%
EPS Next 2Y-66.69%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue Next Year53.35%
Revenue Next 2Y137.9%
Revenue Next 3Y87.81%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UXIN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UXIN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

UXIN's earnings are expected to decrease with -22.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-66.69%
EPS Next 3Y-22.81%

0

5. Dividend

5.1 Amount

UXIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UXIN LTD - ADR

NASDAQ:UXIN (11/4/2024, 8:00:02 PM)

After market: 3.96 +0.03 (+0.76%)

3.93

-0.03 (-0.76%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap738.63M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.75%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 3.45%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.39
Quick Ratio 0.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)67.96%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-4475.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)148.87%
Revenue growth 3Y35.4%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y